Search research articles
Contact Us
Filters
Showing results (181-190 of 193) with videos related to
Page
of 20
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Evaluation of systemic chemotherapy with methotrexate, vinblastine, adriamycin, and cisplatin for advanced bladder cancer. The Japanese Urological Cancer Research Group for Adriamycin
T Kotake, H Akaza, S Isaka, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
September 1, 1984
[Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method]
H Kishi, H Nito, I Saito, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
August 1, 1988
[Clinical study on the effect of CSF-HU (colony stimulating factor human urine) on leukopenia and granulocytopenia induced by cancer chemotherapy--a double-blind study in patients with genito-urinary cancer]
T Niijima, Y Aso, H Akaza, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
December 1, 1987
[Antiemetic effects of MS-5080 associated with cisplatin chemotherapy--an attempt in assessment based on the sample score system using multivariate analysis]
T Niijima, Y Aso, H Akaza, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer. Prospective, randomized, controlled studies of the Japanese Urological Cancer Research Group
H Akaza, S Isaka, K Koiso, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology
|
December 1, 1987
[Clinical experience with extracorporeal shock wave lithotripsy: report of 11 hospitals in Japan]
E Higashihara, T Niijima, H Tanda, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
October 1, 1992
[Combination therapy with natural type human tumor necrosis factor (MHR-24) and human lymphoblastoid interferon-alpha (MOR-22) against renal cell carcinoma--a multiclinic cooperative, early phase II study. Subcommittee on Urogenital Malignancy, Committee on MHR-24 against Tumors]
T Niijima, H Akaza, T Koyanagi, et al.
The Japanese Journal of Antibiotics
|
November 1, 1986
[Clinical evaluation of astromicin administered by intravenous drip infusion. Report III. Bacterial infections in the field of urology]
N Kawamura, K Okada, N Tanaka, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Prophylactic chemotherapy with intravesical instillation of adriamycin and oral administration of 5-fluorouracil after surgery for superficial bladder cancer. The Japanese Urological Cancer Research Group for Adriamycin
K Obata, Y Ohashi, H Akaza, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
September 1, 1983
[Double-blind comparative clinical study of cefpiramide (SM-1652) and cefsulodin on complicated urinary tract infections due to P. aeruginosa]
N Kawamura, M Ohkoshi, K Okada, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 193) with videos related to
Sort By:
Page
of 20
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Evaluation of systemic chemotherapy with methotrexate, vinblastine, adriamycin, and cisplatin for advanced bladder cancer. The Japanese Urological Cancer Research Group for Adriamycin
T Kotake, H Akaza, S Isaka, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
September 1, 1984
[Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method]
H Kishi, H Nito, I Saito, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
August 1, 1988
[Clinical study on the effect of CSF-HU (colony stimulating factor human urine) on leukopenia and granulocytopenia induced by cancer chemotherapy--a double-blind study in patients with genito-urinary cancer]
T Niijima, Y Aso, H Akaza, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
December 1, 1987
[Antiemetic effects of MS-5080 associated with cisplatin chemotherapy--an attempt in assessment based on the sample score system using multivariate analysis]
T Niijima, Y Aso, H Akaza, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer. Prospective, randomized, controlled studies of the Japanese Urological Cancer Research Group
H Akaza, S Isaka, K Koiso, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology
|
December 1, 1987
[Clinical experience with extracorporeal shock wave lithotripsy: report of 11 hospitals in Japan]
E Higashihara, T Niijima, H Tanda, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
October 1, 1992
[Combination therapy with natural type human tumor necrosis factor (MHR-24) and human lymphoblastoid interferon-alpha (MOR-22) against renal cell carcinoma--a multiclinic cooperative, early phase II study. Subcommittee on Urogenital Malignancy, Committee on MHR-24 against Tumors]
T Niijima, H Akaza, T Koyanagi, et al.
The Japanese Journal of Antibiotics
|
November 1, 1986
[Clinical evaluation of astromicin administered by intravenous drip infusion. Report III. Bacterial infections in the field of urology]
N Kawamura, K Okada, N Tanaka, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Prophylactic chemotherapy with intravesical instillation of adriamycin and oral administration of 5-fluorouracil after surgery for superficial bladder cancer. The Japanese Urological Cancer Research Group for Adriamycin
K Obata, Y Ohashi, H Akaza, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
September 1, 1983
[Double-blind comparative clinical study of cefpiramide (SM-1652) and cefsulodin on complicated urinary tract infections due to P. aeruginosa]
N Kawamura, M Ohkoshi, K Okada, et al.
Page
of 20